Cardiovascular adverse events in patients with lung cancer treated with immune checkpoint inhibitors: a nationwide database study. Isawa T, Togashi S, Taguri M, Toi Y, et al. Oncologist 2025;30:oyaf151.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Isawa T, Togashi S, Taguri M, Toi Y, et al. Cardiovascular adverse events in patients with lung cancer treated with immune checkpoint inhibitors: a nationwide database study. Oncologist 2025;30:oyaf151.
PMID: 40549047